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Integrative analysis of multi-omics data is a powerful approach for gaining functional insights into 
biological and medical processes. Conducting these multifaceted analyses on human samples is often 
complicated by the fact that the raw sequencing output is rarely available under open access. the 
Personal Genome Project UK (PGP-UK) is one of few resources that recruits its participants under 
open consent and makes the resulting multi-omics data freely and openly available. as part of this 
resource, we describe the PGP-UK multi-omics reference panel consisting of ten genomic, methylomic 
and transcriptomic data. Specifically, we outline the data processing, quality control and validation 
procedures which were implemented to ensure data integrity and exclude sample mix-ups. In addition, 
we provide a RESt aPI to facilitate the download of the entire PGP-UK dataset. the data are also 
available from two cloud-based environments, providing platforms for free integrated analysis. In 
conclusion, the genotype-validated PGP-UK multi-omics human reference panel described here 
provides a valuable new open access resource for integrated analyses in support of personal and medical 
genomics.
Background & Summary
The Personal Genome Project UK (PGP-UK) is a member of the global PGP network together with the PGPs in 
the United States, Canada, Austria and China. The PGP network aims to provide multi-omics and trait data under 
open access to the community. This contributes to personalised medicine by advancing our understanding of how 
phenotypes and the development of diseases are influenced by genetic, epigenetic, environmental and lifestyle 
factors. While all five PGP centres generate whole-genome sequencing (WGS), some PGPs, such as PGP-UK, 
produce additional multi-omics data.
To participate in this study, volunteers must pass the eligibility criteria (e.g. be a UK citizen or permanent resi-
dent), sign the open consent form and pass a very thorough entrance exam. The objective of the exam is to ensure 
that the participant understands the key PGP-UK procedures and the potential risks of being involved in a project 
of this nature. At present, 1100 subjects have successfully enrolled in the project, and over a hundred of them have 
had their genomes sequenced. Once enrolled, participants are invited for sample collection which involves giving 
a blood or saliva sample or both for DNA and RNA extraction. DNA sequencing is then performed followed by 
data analysis. The results are reported back to the participants in the form of a Genome Report that is made pub-
licly available after a grace period of one month. However, the participant is able to withdraw from the project at 
any time. DNA methylation data is generated using the Illumina HumanMethylation450 BeadChip array (450 k) 
and results are displayed in a freely available Methylome Report, a unique feature of the UK branch of the project. 
The preparation of both Genome and Methylome reports is discussed in more details in the Usage Notes Section.
A pilot cohort of ten members of the public make up the PGP-UK multi-omics reference panel. For this 
cohort, we collected whole-genome bisulfite sequencing (WGBS) and RNA sequencing (RNA-seq) in addition to 
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WGS and 450 k data. Figure 1 shows a schematic of the PGP-UK workflow. More information about PGP-UK can 
be found in1,2 and on the project’s website www.personalgenomes.org.uk.
While controlled access multi-omics data can be submitted into a single public repository (e.g. EGA in 
Europe or dbGaP in the USA), there is currently no single public repository for open access multi-omics data. 
Consequently, the different types of datasets (WGS, WGBS, RNA-seq, 450 k) were submitted to the correspond-
ing repositories (European Nucleotide Archive (ENA), European Variation Archive (EVA), ArrayExpress) at 
EMBL-EBI. The details are given in the Data Records section and direct data download links are provided on the 
PGP-UK data web page www.personalgenomes.org.uk/data. For convenience, we offer a web API to download 
all the available PGP-UK data (see Data Records). The cumulative size of the PGP-UK multi-omics reference 
panel exceeds 2TB, which means that it would take over 3 days (more than 85 hours) to download (with mean 
UK download speed of 54.2 Mbps, Ofcom 2018). To overcome this limitation, we collaborated with two cloud 
platform providers (Seven Bridges Genomics and Lifebit) to host PGP-UK data in their respective clouds for 
unrestricted access as briefly described in Data Records section.
In this paper, we describe the PGP-UK multi-omics human reference panel derived from 10 participants. 
We followed best practices to perform various quality control (QC) checks to ensure the quality of the pilot 
WGS, WGBS, RNA-seq and 450 k datasets as described in the Technical Validation section. Finally, we describe 
the methods employed for multi-omics data matching, which ensures that samples are mapped to the correct 
participant.
Methods
Ethics. The PGP-UK study is approved by the University College London (UCL) Research Ethics Committee 
(ID Number 4700/001) subject to annual reviews and renewals. All the research activities in the project are con-
ducted in accordance with the Declaration of Helsinki, UK national laws and medical research regulatory require-
ments. Prior to their enrolment, every participant must pass an entrance exam, give their consent to participate 
in the project and agree for their data and associated reports to be made publicly available under open access.
tissue samples. Blood samples were collected using EDTA Vacutainers (Becton Dickinson). Saliva samples 
were collected using Oragene OG-500 self-sampling kits. Sample processing and storage protocols were in line 
with HTA-approved standard operating procedures.
Fig. 1 PGP-UK workflow. Horizontal panels depict the general sample/data categories and options (e.g blood 
and/or saliva) and vertical panels depict specific data types and their flow from start to end.
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Whole-genome sequencing (WGS). WGS libraries were prepared from whole blood DNA using Illumina 
TruSeq Nano in accordance with standard operating procedures. Illumina TruSeq Nano is a PCR-based method 
which, like all PCR-based methods, has limitations compared to PCR-free methods3–5. In addition, recent stud-
ies have shown that algorithms used to call copy number variation (CNV) from PCR-based library such as 
EnsembleCNV6 can be adapted to identify CNV regions from WGS data7. This indicates that PGP-UK WGS data 
can still be used to call CNV regions with good degree of accuracy.
Sequencing was performed on an Illumina HiSeq X Ten platform with an average depth of 30X. The resulting 
reads were trimmed using TrimGalore software, mapped to the human reference genome hg19 (GRCh37) 
using BWA-MEM algorithm (BWA v. 0.7.128). Ambiguously mapped reads (MAPQ <10) and duplicated reads 
were removed using SAMtools v. 1.29 and Picard v. 1.130 respectively. Genomic variants were called follow-
ing the Genome Analysis Toolkit software (GATK v. 3.4–46) best practices10.
The corresponding FASTQ, BAM and VCF files were deposited in European Nucleotide Archive (ENA) with 
with study ID PRJEB1752911.
Whole-genome bisulfite sequencing (WGBS). DNA was extracted from blood samples followed by 
bisulfite conversion and library preparation using the TruMethyl Whole Genome Kit v2.1. WGBS was performed 
on an Illumina HiSeq X Ten platform with an average depth of 15X. Generated FASTQ files were processed using 
GemBS v. 0.11.7 software12.
Resulting FASTQ and BAM files were deposited in the ENA with with study ID PRJEB1752911.
RNa Sequencing (RNa-seq). RNA-seq was performed using 20 ng of RNA isolated from whole blood. 
All the involved procedures were implemented in accordance with the corresponding manufacturers’ protocols.
Libraries for RNA-seq were prepared with SENSE mRNA-seq Library Prep Kit v2, purified and amplified 
(18 PCR cycles). After adding adapters and indices, sequencing libraries were further purified using Solid Phase 
Reversible Immobilisation beads. The output was QC-verified and quantified using Qubit fluorometer. Finally, 
library QC was performed on Bioanalyzer 2100 and further quantified by qPCR with KAPA library quantification 
kit and the sequencing was performed on Illumina HiSeq 4000.
RNA-seq FASTQ files are available to download from the ArrayExpress (accession ID E-MTAB-652313) and 
ENA (project ID PRJEB2513914).
DNA methylation profiling. Genomic DNA (500 ng) extracted from whole blood and saliva was bisulfite 
converted using the EZ DNA Methylation Kit (Zymo Research) following the recommended incubation con-
ditions for 450 k. Methylation profiling was subsequently performed on 450 k arrays using Illumina iScan 
Microarray Scanner at UCL Genomics, in accordance with standard operating procedures.
Raw DNA methylation array data (IDAT files) for PGP-UK participants were submitted to the ArrayExpress 
repository with accession number E-MTAB-537715.
Data Records
The entire PGP-UK dataset is freely available for download from public repositories with no access restrictions. 
Links for the particular datasets are provided on the PGP-UK website (www.personalgenomes.org.uk). Accession 
numbers and dataset identifiers are presented in Table 1. Basic phenotype data, which includes self-reported age, 
sex, smoking status, etc., alongside with genome and methylome reports, generated by the PGP-UK, can be found 
on the project’s data web page www.personalgenomes.org.uk/data. Furthermore, all of the data (including associ-
ated metadata) are available through the PGP-UK API. The API is compliant with the Open API Specification 3.0 
and is documented at www.personalgenomes.org/api.
Whole genome sequencing and whole genome bisulfite sequencing data are freely available from the ENA 
under the project ID PRJEB1752911. RNA-seq data is deposited in ArrayExpress under the accession number 
E-MTAB-652313 and in ENA PRJEB2513914. DNA methylation array data for PGP-UK participants is stored in 
ArrayExpress under the accession number E-MTAB-537715.
The PGP-UK pilot dataset described in2 resulted in the PGP-UK multi-omics reference panel 
described here. The datasets are available from the above-mentioned repositories and from the 
Seven Bridges Cancer Genomics cloud (docs.cancergenomicscloud.org/docs/
personal-genome-project-uk-pgp-uk-pilot-dataset), which offers various tools and work-
flows for genomic and epigenomic data analysis.
The PGP-UK multi-omics reference panel is also available in the Lifebit cloud through their Open Data pro-
ject (opendata.lifebit.ai/table/pgp) along with interactive analyses (ancestry, phenotypic traits, 
genetic variance) and custom pipelines provided by Lifebit’s cloud-computing platform Deploit (deploit.
lifebit.ai). As a part of our collaboration with Lifebit our data have also been uploaded to a public Amazon 
Web Services (AWS) Simple Storage Service (S3) Bucket. This S3 Bucket is available at https://s3.console.aws.
amazon.com/s3/buckets/pgp-lifebit (publically accessible with an AWS account) and can be used independently 
of the Lifebit platform within AWS or any other cloud platform using AWS S3 APIs.
To provide maximum access, PGP-UK data can in principle be hosted in any cloud complying with ‘best 
practices’ as well as adequate legal and ethical governance16. To this end, we have initiated discussions to also host 
our data under the Early Adopter Programme of the European Open Science Cloud (https://www.eosc-portal.
eu/) and with Open Humans (https://www.openhumans.org/) which opened their project to global members in 
March 2019.
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technical Validation
In this section, we describe the outcomes of the PGP-UK data quality control checks and validation for the pilot 
cohort. In a first instance, we describe the QC framework and discuss outputs for each types of data collected. 
Then, we provide details of multi-omics data matching validation procedures based on cross-comparison of var-
iants between different data types for each individual.
Data quality control. WGS data QC. Quality control of the reported WGS data was performed using 
FastQC v. 0.11.2 (https://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and Picard v. 1.130 (https://
github.com/broadinstitute/picard) tools. QC reports were generated using MultiQC v. 1.5 software17.
The WGS data average median coverage is above 35X (varies between 30X and 47X across samples) with more 
than 73% of the bases covered reaching 30X or more (varies between 54% and 95% across samples), see Fig. 2(a). 
A summary of the WGS QC analysis is presented in Table 2.
WGBS data QC. GemBS v. 3.2.1, FastQC v. 0.11.7 and Picard v. 2.18.23 tools were used in quality control of 
the PGP-UK WGBS and data QC reports were generated using MultiQC v. 1.5 software17.
WGBS average median coverage is above 14X (ranging from 10X to 16X across samples) with more than 19% 
of bases covered reaching 30X or deeper (varies between 15% and 25% across samples), see Fig. 2(b). Summary of 
the WGBS QC analysis is presented in Table 3.
RNA-seq data QC. All of the RNA-seq samples were processed with a modified version of the nextflow18 
nf-core RNA-seq pipeline (https://github.com/UCL-BLIC/rnaseq). Specifically, reads were trimmed with 
TrimGalore v. 0.4.1, aligned against hg19 with STAR v. 2.5.2a19 and duplicated reads were identified and 
removed with Picard v. 2.18.9 tools. QC reports were generated using MultiQC v. 1.517 as part of the same 
pipeline. Reads were further split and trimmed using GATK4.
The mean RNA integrity number (RIN) value of the RNA used for sequencing was 8.55 (ranging between 7.1 
and 9.3). Figure 2(c) demonstrates the distribution of mapped reads over various genomic features. A summary 
of the RNA-seq QC analysis is presented in Table 4.
450 k methylation data QC. 450 k DNA methylation profiles were generated from whole blood and saliva for 
each of the ten participants in the PGP-UK multi-omics reference panel. For quality control of these data, we used 
R v. 3.5.2 with minfi v. 1.28.3 and ewastools v. 1.4 libraries20,21.
We performed quality checks based on 17 metrics assessed at control probes as described in the Illumina’s 
BeadArray Controls Reporter. All 17 metrics derived from the array control probes’ data are within the manufac-
turer’s recommended thresholds. In addition, we analysed detection p-values and bead count information, which 
is available for 100% and 99.92% of CpGs respectively. 99.96% of the detection p-values are below the threshold 
Sample ID EBI ID Tissue
WGS WGBS 450 k RNA-seq
ENA
PRJEB17529
ENA
PRJEB17529
Array Express
E-MTAB-5377
ENA
PRJEB25139
uk35C650 SAMEA4545245
blood
ERX1796409 ERX2408504
101130760050_R04C02
ERX2373318
saliva 101130760049_R03C01
uk2E2AAE SAMEA4545246
blood
ERX1796410 ERX2408505
101130760050_R05C02
ERX2373321
saliva 101130760050_R03C01
uk2DF242 SAMEA4545247
blood
ERX1796411 ERX2408506
101130760049_R06C02
ERX2373317
saliva 101130760049_R03C02
uk740176 SAMEA4545248
blood
ERX1796412 ERX2408507
101130760050_R06C02
ERX2373324
saliva 101130760050_R06C01
uk33D02F SAMEA4545249
blood
ERX1796413 ERX2408508
101130760049_R05C02
ERX2373316
saliva 101130760049_R04C02
uk0C72FF SAMEA4545250
blood
ERX1796414 ERX2408509
101130760049_R06C01
ERX2373322
saliva 101130760050_R01C01
uk1097F9 SAMEA4545251
blood
ERX1796415 ERX2408510
101130760050_R02C01
ERX2373320
saliva 101130760050_R01C02
uk174659 SAMEA4545252
blood
ERX1796416 ERX2408511
101130760050_R05C01
ERX2373325
saliva 101130760049_R05C01
uk85AA3B SAMEA4545253
blood
ERX1796417 ERX2408512
101130760049_R02C02
ERX2373323
saliva 101130760049_R01C01
uk481F67 SAMEA4545254
blood
ERX1796418 ERX2408513
101130760049_R02C01
ERX2373319
saliva 101130760050_R02C02
Table 1. PGP-UK data identifiers for the reference panel comprised of 10 PGP-UK participants. For each of 
them WGS, WGBS and RNA-seq data were obtained from blood samples, methylation profiles were obtained 
using 450 k from both blood and saliva samples. The table contains ENA accession numbers for WGS, WGBS 
and RNA-seq, for 450 k data it shows Sentrix IDs and positions, separated by the underscores.
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of 0.01. Average CpG bead count number across all samples is 14, and 100% of the available bead count numbers 
≥3. A summary of this analysis is presented in Table 5. Figure 2(d) shows the overlay of the β-value density dis-
tributions for all samples.
Multi-omics data matching. In order to ensure data integrity and exclude the possibility of sample mix-up 
between study participants, we validated our sample assignments, by matching the available 450 k, WGBS 
and RNA-seq data against WGS. First, we matched the 450 k against WGS data for each participant using 65 
single nucleotide polymorphisms (SNP) control probes from Illumina 450 k array. Second, we matched the 
WGBS-derived genotypes for the same 65 SNP loci with the WGS data. Third, we compared genotypes derived 
from RNA-seq and WGS data based on the set of loci from protein coding regions. The schema of the multi-omics 
data matching is given in Fig. 3(a) and further details are provided below.
We used β-values recorded at the 65 450 k SNP control probes to distinguish between heterozygous and 
homozygous alleles in the 450 k dataset. These SNPs are by design highly variable and can therefore provide a 
unique genetic signature that can be used to differentiate between each study participant. Note that 64 out of these 
Fig. 2 PGP-UK QC images for WGS, WGBS, RNA-seq and 450 k methylation data. (a) WGS coverage depth 
plot. (b) WGBS coverage depth plot. (c) RNA-seq reads distribution over the different genome features. (d) 
Density plot for Illumina 450 k methylation profiles.
Sample ID
Median
Coverage
Bases
≥30X
Duplicated 
Reads, % GC Content, %
Read 1 Read 2 Read 1 Read 2
uk35C650 32.0X 64% 8.0% 6.3% 40% 41%
uk2E2AAE 47.0X 95% 18.3% 18.4% 41% 41%
uk2DF242 35.0X 75% 10.2% 13.6% 41% 41%
uk740176 35.0X 80% 8.3% 9.6% 40% 41%
uk33D02F 31.0X 58% 11.2% 12.1% 41% 41%
uk0C72FF 31.0X 57% 3.7% 8.1% 41% 41%
uk1097F9 39.0X 85% 4.5% 12.7% 40% 41%
uk174659 35.0X 78% 8.5% 15.1% 41% 41%
uk85AA3B 37.0X 85% 6.1% 3.2% 41% 41%
uk481F67 30.0X 54% 8.6% 7.0% 41% 41%
Table 2. Quality control metrics summary of the WGS data derived from blood samples of 10 PGP-UK 
participants. The table contains median coverage depth, percentage of bases covered with at least 30X depth, as 
well as duplicated reads and GC contents percentages for both forward and reverse reads for each sample.
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65 SNPs are outside protein-coding regions and, hence, not available for the RNA-seq data. We identified 279 SNP 
loci present in at least 4 WGS samples which were also highly expressed across RNA-seq samples (in the top 100 
most expressed genes) yielding a suitable validation set for the WGS vs. RNA-seq comparison.
To match the different datasets, we extracted the locations of the loci used for validation (65 loci 
for the WGS vs. 450 k and WGBS vs. 450 k comparisons, and 279 loci for WGS vs. RNA-seq) and used the 
HaplotypeCaller and GenotypeGVCFs tools from (GATK v. 3.8.0) on the corresponding BAM files to 
force the call of genotypes in these locations. Percentage of matching genotypes were then obtained across sam-
ples and datasets to confirm sample identity as presented on Fig. 3 and Table 6.
WGS vs. 450 k. In order to obtain genotype information from 450 k data, we extracted β-values for the 65 SNP 
control probes for each of the 10 PGP-UK participants. As expected, these β-values clustered into three separate 
peaks around 0.5 (which corresponds to heterozygous genotypes), 0 and 1 (which correspond to homozygous 
genotypes). We checked and confirmed that reported β-values for all SNP control probes which were derived 
from the whole blood and corresponding saliva 450 k datasets were a 100% match. In other words, we established 
that the zygosity of each probe was the same across both DNA samples for any given participant.
We then extracted the genotypes for those 65 SNPs from WGS and matched them with to the corresponding 
zygosity in the 450 k data. This resulted in perfect 100% match for corresponding samples, i.e. samples from the 
same participant, see Fig. 3(b) and Table 6.
WGS vs. WGBS. This comparison was performed by matching WGS- and WGBS-derived genotypes for 65 
Illumina 450 k array SNP control probes. The mean agreement between matched samples was 99.45%, which 
corresponds to a total of 3 loci mismatch observed in 3 out of ten participants (i.e. a single mismatch for each 
of those three participants). Altogether, 100% and 84.77% of 65 SNPs had coverage in the WGS and WGBS data 
respectively, which allowed us to make our comparison based on 51–61 common loci per participant, see Fig. 3(c) 
and Table 6.
Sample ID
Median
Coverage
Bases
≥30X
Duplicated Reads, % GC Content, %
Read 1 Read 2 Read 1 Read 2
uk35C650 10.0X 15% 27.3% 13.3% 26% 29%
uk2E2AAE 15.0X 20% 39.4% 20.3% 24% 27%
uk2DF242 16.0X 23% 28.0% 12.4% 24% 27%
uk740176 15.0X 20% 25.8% 12.6% 25% 27%
uk33D02F 16.0X 20% 26.3% 13.1% 24% 27%
uk0C72FF 14.0X 18% 26.8% 11.4% 25% 28%
uk1097F9 14.0X 15% 26.0% 10.8% 24% 27%
uk174659 14.0X 17% 27.1% 15.5% 24% 27%
uk85AA3B 16.0X 19% 28.3% 14.9% 24% 27%
uk481F67 15.0X 25% 31.6% 17.4% 26% 29%
Table 3. Quality control metrics summary of the WGBS data derived from blood samples of 10 PGP-UK 
participants. The table contains median coverage depth, percentage of bases covered with at least 30X depth, as 
well as duplicated reads and GC contents percentages for both forward and reverse reads for each sample.
Sample ID RIN
Uniquely
Aligned, %
Duplicated Reads, % GC Content, %
Read 1 Read 2 Read 1 Read 2
uk35C650 8.8 88.8% 83.2% 80.6% 53% 56%
uk2E2AAE 9.1 89.3% 85.9% 82.3% 53% 56%
uk2DF242 9.2 90.0% 86.3% 81.9% 53% 56%
uk740176 8.5 90.0% 84.8% 80.6% 53% 56%
uk33D02F 8.3 87.0% 85.5% 82.6% 53% 56%
uk0C72FF 7.9 86.7% 85.0% 82.5% 53% 56%
uk1097F9 8.7 86.1% 86.5% 82.6% 54% 57%
uk174659 9.3 90.4% 84.4% 81.3% 53% 56%
uk85AA3B 8.6 89.0% 84.9% 81.2% 53% 56%
uk481F67 7.1 90.4% 87.3% 83.7% 52% 55%
Table 4. Quality control metrics summary of the RNA-seq data derived from blood samples of 10 PGP-UK 
participants. The table contains RIN value, percentages of uniquely aligned bases, as well as duplicated reads and 
GC contents percentages for both forward and reverse reads for each sample.
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WGS vs. RNA-seq. To match RNA-seq with WGS samples, we used a set of common loci in highly expressed 
genes as described above. Available genotypes for these loci were extracted from the RNA-seq and WGS samples 
and cross-validated. In total, 92.65% and 80.93% of these 279 loci had coverage in the RNA-seq and WGS data 
respectively, which allowed us to make our comparison based on 152–197 loci per participant. On average, cor-
responding WGS and RNA-seq data are in agreement for 76.17% of genotype calls (range 69.68–83.23%), see 
Fig. 3(d) and Table 6.
Results of matching 450 k, RNA-seq and WGBS data with WGS are presented in Table 6. The correlation plots 
presented on Fig. 3, demonstrate a substantially higher level of correspondence between samples from the same 
individual compared to those from different people when comparing WGS vs. 450 k (Fig. 3(b)), WGS vs. WGBS 
(Fig. 3(c)) and WGS vs. RNA-seq (Fig. 3(d)).
Usage Notes
Here we describe two key outputs generated for each PGP-UK participant, the Genome and Methylome Reports. 
These reports are freely available to download on PGP-UK website, see https://www.personalgenomes.org.uk/
data/.
Genome Reports leverage the information from variant call files (VCFs) and provide an overview of the 
potential influence of genetic variants on several genetic traits, as well as ancestry information. Potentially ben-
eficial or harmful traits for each participant were identified using public data from SNPedia22, gnomAD v2.0.223, 
GetEvidence24 and ClinVar25. Plots to visualise the ancestry of each participant were created by applying principal 
component analysis (as implemented in Plink v1.926) on a genotype matrix resulting from merging the partic-
ipant genotypes with those from 2504 unrelated samples from 26 worldwide populations available from the 1000 
Genomes Project27. Population membership proportions were obtained using the Admixture v1.3.0 software28 
on above-mentioned genotype matrix.
Methylome reports contain epigenetic age and smoking status prediction for PGP-UK participants based 
on their methylome as assessed by 450 k array experiments. Raw data were processed, quality controlled and 
analysed using ChAMP29,30 and minfi20 pipelines for R. Epigenetic age calculation was based on the multi-tissue 
Horvath clock31, which predicts age using a linear combination of the methylation levels from a reference panel 
of 353 CpGs. Smoking status was predicted by calculating smoking scores as linear combinations of the methyla-
tion levels at 183 CpGs and then comparing them to a particular threshold as described in32. More details on the 
PGP-UK Genome and Methylome reports are described in2.
Outlook
Because of its open access status, the PGP-UK multi-omics reference panel described here has the potential to 
become the reference panel of choice for the implementation of the FAIR (Findable, Accessible, Interoperable, 
Reusable) principles33 for data sharing and the integration of new data standards and formats. While we shall 
aim to increase the size of the panel in the longer term, the immediate aim is to add more data. Towards this, 
Sample ID Tissue
Detection p-values Bead Count
Available, % p < 0.01, % Available, % n ≥ 3, %
uk35C650
blood 100% 99.98476% 99.91370% 100%
saliva 100% 99.97899% 99.93710% 100%
uk2E2AAE
blood 100% 99.92297% 99.92503% 100%
saliva 100% 99.93491% 99.93670% 100%
uk2DF242
blood 100% 99.96478% 99.90896% 100%
saliva 100% 99.97178% 99.92110% 100%
uk740176
blood 100% 99.91638% 99.90361% 100%
saliva 100% 99.91638% 99.91800% 100%
uk33D02F
blood 100% 99.92791% 99.91761% 100%
saliva 100% 99.92771% 99.93120% 100%
uk0C72FF
blood 100% 99.97467% 99.90484% 100%
saliva 100% 99.98558% 99.88910% 100%
uk1097F9
blood 100% 99.98929% 99.92460% 100%
saliva 100% 99.98744% 99.92150% 100%
uk174659
blood 100% 99.97714% 99.94151% 100%
saliva 100% 99.97899% 99.92190% 100%
uk85AA3B
blood 100% 99.93327% 99.89351% 100%
saliva 100% 99.94089% 99.91670% 100%
uk481F67
blood 100% 99.98126% 99.91514% 100%
saliva 100% 99.98105% 99.92130% 100%
Table 5. Quality control metrics summary of the Illumina 450 k data derived from blood and saliva samples of 
10 PGP-UK participants. The table contains percentages of available detection p-values and bead count numbers 
together with percentages of p < 0.01 and bead count numbers 3 and above for each sample.
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we have already generated methylation count files (MCFs) which are the epigenetic equivalent to variant count 
files (VCFs). These pre-processed data files are very popular with users for downstream analyses. While agreed 
standards and procedures are in place for generating and depositing VCFs into public databases, PGP-UK is at 
the forefront of helping to establish these for MCFs in collaboration with EBI (https://www.ebi.ac.uk) and ELIXIR 
(https://elixir-europe.org/). In addition, PGP-UK is spearheading efforts to add Phenopackets to our reference 
Fig. 3 Multi-Omics Data Matching. (a) Multi-Omics Data Matching Schema. 65 loci were used in matching 
WGS with methylation and WGBS data, 279 loci were used in matching WGS with RNA-seq data. (b) 
Correlation plot displaying matching results for WGS vs. 450 k datasets. (c) Correlation plot displaying 
matching results for WGS vs. WGBS datasets. (d) Correlation plot displaying matching results for WGS vs. 
RNA-seq datasets. On correlation plots (b–d) scale is represented by the combination of ball size and colour 
(from white to dark blue) and goes from 0 (0% match) to 1 (perfect 100% match).
Sample ID
WGS vs. 450 k WGS vs. WGBS WGS vs. RNA-seq
Loci, n Loci, % matched, % Loci, n Loci, % matched, % Loci, n Loci, % matched, %
uk35C650 65 100 100 52 80 100 161 57.71 81.99
uk2E2AAE 65 100 100 51 78.46 100 172 61.65 75.58
uk2DF242 65 100 100 58 89.23 100 183 65.59 70.49
uk740176 65 100 100 61 93.85 98.36 152 54.48 80.26
uk33D02F 65 100 100 53 81.54 100 188 67.38 69.68
uk0C72FF 65 100 100 57 87.69 98.25 159 56.99 81.13
uk1097F9 65 100 100 54 83.08 98.15 190 68.10 73.68
uk174659 65 100 100 52 80 100 197 70.61 74.62
uk85AA3B 65 100 100 60 92.30 100 167 59.86 83.23
uk481F67 65 100 100 53 81.54 100 169 60.57 71.01
Table 6. Summary of data cross-validation between 450 k, WGBS and RNA-seq against WGS. Columns Loci, n 
and Loci, % contain respective numbers and percentages of loci used for matching (out of 65 loci for WGS and 
WGBS vs. 450 k and out of 279 loci for WGS vs. RNA-seq).
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panel. PhenoPackets are represented as phenotype exchange files (PXFs), a novel open standard for sharing dis-
ease and phenotype information (http://phenopackets.org). For disease and health information in general, we 
are currently exploring with Patients Know Best (https://www.patientsknowbest.com/) how to link our reference 
panel to the corresponding NHS health records. All these activities are conducted in compliance and collabora-
tion with EU standards for precision medicine, EU-STANDS4PM (https://www.eu-stands4pm.eu/).
Code availability
All the PGP-UK data pre-processing, QC and analyses were performed with publicly available software packages, 
using versions and parameters described in the paper.
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